Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Health-related quality of life after heart transplantation].
Tegtbur U, Pethig K, Jung K, Machold H, Haverich A, Busse MW, Brinkmeier U. Tegtbur U, et al. Among authors: jung k. Z Kardiol. 2003 Aug;92(8):660-7. doi: 10.1007/s00392-003-0934-3. Z Kardiol. 2003. PMID: 12955413 German.
[Phase III rehabilitation after heart transplantation].
Tegtbur U, Busse MW, Jung K, Markofsky A, Machold H, Brinkmeier U, Künsebeck HW, Haverich A, Pethig K. Tegtbur U, et al. Among authors: jung k. Z Kardiol. 2003 Nov;92(11):908-15. doi: 10.1007/s00392-003-0968-6. Z Kardiol. 2003. PMID: 14634760 Clinical Trial. German.
Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.
Jeong H, Ryu J, Jeong JH, Han S, Hyung J, Ahn JH, Jung KH, Kim SB, Jeong BK, Lee HJ, Gong G, Moon DH. Jeong H, et al. Among authors: jung kh. Eur J Nucl Med Mol Imaging. 2025 Jan 14. doi: 10.1007/s00259-024-07058-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 39806206
Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: jung k. Breast Cancer Res. 2025 Jan 7;27(1):3. doi: 10.1186/s13058-024-01952-0. Breast Cancer Res. 2025. PMID: 39773237 Free PMC article. No abstract available.
6,909 results